Clinical trial of photodynamic therapy with meso-tetra (Hydroxyphenyl) chlorin for respiratory papillomatosis

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 2, 2005, Pages 99-105

  Shikowitz, Mark J ^a,f   Abramson, Allan L ^a   Steinberg, Bettie M ^a,b   DeVoti, James ^a,b   Bonagura, Vincent R ^a,b   Mullooly, Virginia ^a   Nouri, May ^a,b   Ronn, Avigdor M ^a   Inglis, Andrew ^c   McClay, John ^d   Freeman, Kathrine ^e  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^b N Shore Long Isl Jewish Hlth S   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT; TETRA(HYDROXYPHENYL)CHLORIN; UNCLASSIFIED DRUG; VIRUS DNA;

ADOLESCENT; ADULT; AIRWAY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EDEMA; ENDOSCOPY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LARYNX DISORDER; LATENT VIRUS INFECTION; MALE; MULTICENTER STUDY; PAPILLOMATOSIS; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT TUMOR; SCORING SYSTEM; SIDE EFFECT; TRACHEA DISEASE; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR REGRESSION; WART VIRUS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MESOPORPHYRINS; MIDDLE AGED; PAPILLOMA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 13444262220     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.2.99     Document Type: Article

References (25)

1. Steinberg BM, Topp W, Schneider PS, Abramson AL. Laryngeal papillomavirus infection during clinical remission. N Engl J Med. 1983;308:1261-1264.
2. Abramson AL, Nouri M, Mullooly V, Fisch G, Steinberg BM. Latent human papillomavirus infection is comparable in the larynx and trachea. J Med Virol. 2004;72:473-477.
3. Broker TR, Jin G, Croom-Rivers A, et al. Viral latency: the papillomavirus model. Dev Biol (Basel). 2001;106:443-451.
4. H2 cytokine imbalance. Clin Immunol. 1999;93:302-311.
5. DeVoti JA, Steinberg BM, Rosenthal DW, et al. Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis. Clin Diagn Lab Immunol. 2004;11:538-547.
6. Healy GB, Gelber RD, Trowbridge AL, Grundfast KM, Ruben RJ, Price KN. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. N Engl J Med. 1988;319:401-407.
7. Kashima H, Leventhal B, Clark K, et al. Interferon α-Na in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions. Laryngoscope. 1988;98:334-340.
8. Auborn KJ. Therapy for recurrent respiratory papillomatosis. Antivir Ther. 2002;7:1-9.
9. Rosen CA, Bryson PC. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice. 2004;18:248-253.
10. Pashley NR. Can mumps vaccine induce remission in recurrent respiratory papilloma? Arch Otolaryngol Head Neck Surg. 2002;128:783-786.
11. Pransky SM, Magit AE, Kearns DB, Kang DR, Duncan NO. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg. 1999;125:1143-1148.
12. Shikowitz MJ, Steinberg BM, Abramson AL. Hematoporphyrin derivative therapy of papillomas: experimental study. Arch Otolaryngol Head Neck Surg. 1986;112:42-46.
13. Abramson AL, Shikowitz MJ, Mullooly VM, Steinberg BM, Amela CA, Rothstein HR. Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch Otolaryngol Head Neck Surg. 1992;118:25-29.
14. Abramson AL, Shikowitz MJ, Mullooly VM, Steinberg BM, Hyman RB. Variable light dose effect on photodynamic therapy of laryngea papillomas. Arch Otolaryngol Head Neck Surg. 1994;120:852-855.
15. Shikowitz MJ, Abramson AL, Freeman K, et al. Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope. 1998;108:962-967.
16. Ronn AM, Nouri M, Lofgren LA, et al. Human tissue levels and plasma pharmacokinetics of temoporfin (Foscan, mTHPC). Lasers Med Sci. 1996;11:267-272.
17. Ronn AM, Batti J, Lee CJ, et al. Comparative biodistribution of meta-tetra (hydroxyphenyl) chlorin in multiple species: clinical implications for photodynamic therapy. Lasers Surg Med. 1997;20:437-442.
18. Lofgren LA, Ronn AM, Abramson AL, et al. Photodynam c therapy using m-tetra (hydroxyphenyl) chlorin: an animal model. Arch Otolaryngol Head Neck Surg. 1994;120:1355-1362.
19. 2 laser treatment in 244 patients with respiratory papillomas. Laryngoscope. 2001;111:1639-1644.
20. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889-905.
21. Korbelik M, Dougherty GJ. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res. 1999;59:1941-1946.
22. van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology. 2003;207:105-113.
23. Ohashi PS, DeFranco AL. Making and breaking tolerance. Curr Opin Immunol. 2002;14:744-759.
24. Bonagura VR, Vambutas A, DeVoti JA, et al. HLA alleles, IFN-γ responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol. 2004;65:773-782.
25. Vambutas A, Bonagura VR, Reed EF, et al. Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11. J Infect Dis. 2004;189:871-879.